260 related articles for article (PubMed ID: 36325577)
21. mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment.
Mafi S; Mansoori B; Taeb S; Sadeghi H; Abbasi R; Cho WC; Rostamzadeh D
Front Immunol; 2021; 12():774103. PubMed ID: 35250965
[TBL] [Abstract][Full Text] [Related]
22. Cell Fate Control by Translation: mRNA Translation Initiation as a Therapeutic Target for Cancer Development and Stem Cell Fate Control.
Kim HJ
Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31671902
[TBL] [Abstract][Full Text] [Related]
23. Glucose controls co-translation of structurally related mRNAs
Bulfoni M; Bouyioukos C; Zakaria A; Nigon F; Rapone R; Del Maestro L; Ait-Si-Ali S; Scharfmann R; Cosson B
Front Endocrinol (Lausanne); 2022; 13():949097. PubMed ID: 35992129
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation.
George A; Panda S; Kudmulwar D; Chhatbar SP; Nayak SC; Krishnan HH
J Biol Chem; 2012 Feb; 287(7):5042-58. PubMed ID: 22184107
[TBL] [Abstract][Full Text] [Related]
25. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.
Saini KS; Loi S; de Azambuja E; Metzger-Filho O; Saini ML; Ignatiadis M; Dancey JE; Piccart-Gebhart MJ
Cancer Treat Rev; 2013 Dec; 39(8):935-46. PubMed ID: 23643661
[TBL] [Abstract][Full Text] [Related]
26. PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types.
Britten CD
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1395-409. PubMed ID: 23443307
[TBL] [Abstract][Full Text] [Related]
27. Signaling Pathways Involved in the Regulation of mRNA Translation.
Roux PP; Topisirovic I
Mol Cell Biol; 2018 Jun; 38(12):. PubMed ID: 29610153
[TBL] [Abstract][Full Text] [Related]
28. Crosstalks between translation and metabolism in cancer.
Biffo S; Manfrini N; Ricciardi S
Curr Opin Genet Dev; 2018 Feb; 48():75-81. PubMed ID: 29153483
[TBL] [Abstract][Full Text] [Related]
29. Targeted inhibition of mRNA translation initiation factors as a novel therapeutic strategy for mature B-cell neoplasms.
Taylor J; Yeomans AM; Packham G
Explor Target Antitumor Ther; 2020 Feb; 1(1):3-25. PubMed ID: 32924027
[TBL] [Abstract][Full Text] [Related]
30. New insights into 4E-BP1-regulated translation in cancer progression and metastasis.
Wang J; Ye Q; She QB
Cancer Cell Microenviron; 2014; 1(5):. PubMed ID: 26005705
[TBL] [Abstract][Full Text] [Related]
31. Two distinct nodes of translational inhibition in the Integrated Stress Response.
Ryoo HD; Vasudevan D
BMB Rep; 2017 Nov; 50(11):539-545. PubMed ID: 28803610
[TBL] [Abstract][Full Text] [Related]
32. Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.
Steelman LS; Franklin RA; Abrams SL; Chappell W; Kempf CR; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo P; Ruvolo V; Evangelisti C; Martelli AM; McCubrey JA
Leukemia; 2011 Jul; 25(7):1080-94. PubMed ID: 21494257
[TBL] [Abstract][Full Text] [Related]
33. Targeting cap-dependent translation to inhibit Chikungunya virus replication: selectivity of p38 MAPK inhibitors to virus-infected cells due to autophagy-mediated down regulation of phospho-ERK.
Mudaliar P; Pradeep P; Abraham R; Sreekumar E
J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34328830
[TBL] [Abstract][Full Text] [Related]
34. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
Guenther MK; Graab U; Fulda S
Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
[TBL] [Abstract][Full Text] [Related]
35. Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras/MEK/ERK and PI3K/Akt/mTOR pathways.
Rosenberg L; Yoon CH; Sharma G; Bertagnolli MM; Cho NL
Carcinogenesis; 2018 May; 39(5):681-688. PubMed ID: 29538717
[TBL] [Abstract][Full Text] [Related]
36. Ribosome Elongation Stall Directs Gene-specific Translation in the Integrated Stress Response.
Young SK; Palam LR; Wu C; Sachs MS; Wek RC
J Biol Chem; 2016 Mar; 291(12):6546-58. PubMed ID: 26817837
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Translational Control in the Integrated Stress Response by Polysome Profiling.
Holmes MJ; Misra J; Wek RC
Methods Mol Biol; 2022; 2428():157-171. PubMed ID: 35171479
[TBL] [Abstract][Full Text] [Related]
38. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
39. A (dis)integrated stress response: Genetic diseases of eIF2α regulators.
English AM; Green KM; Moon SL
Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1689. PubMed ID: 34463036
[TBL] [Abstract][Full Text] [Related]
40. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.
Steelman LS; Abrams SL; Whelan J; Bertrand FE; Ludwig DE; Bäsecke J; Libra M; Stivala F; Milella M; Tafuri A; Lunghi P; Bonati A; Martelli AM; McCubrey JA
Leukemia; 2008 Apr; 22(4):686-707. PubMed ID: 18337767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
